Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

The Tumor Microenvironment

The Tumor Microenvironment

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

HemaSphere·2026

Same author

Immunogenomic profiles of HIV-associated classic Hodgkin lymphoma from Malawi.

Blood global hematology·2026

Same author

Spatially decoding genotype-associated epigenetic landscapes in human lymphoma FFPE tissues via epi-Patho-DBiT.

Nature communications·2026

Same author

Human Lymph Node Cellular Senescence Atlas Reveals Age-Dependent Alteration in Germinal Center B Cell Function and Niches.

bioRxiv : the preprint server for biology·2026

Same author

Single-cell spatial multi-omics molecular pathology enabled by SuperFocus.

bioRxiv : the preprint server for biology·2026

Same author

Correction: Shared genomic features of HIV+ diffuse large B-cell lymphoma in two African cohorts.

Scientific reports·2026

Same journal

Molecular Pathology in Contemporary Surgical Practice.

Surgical pathology clinics·2026

Same journal

Beyond Blood: Liquid biopsy assays for nonplasma body fluids.

Surgical pathology clinics·2026

Same journal

The Molecular Landscape of Ovarian Neoplasms: A Review.

Surgical pathology clinics·2026

Same journal

Clinically Relevant Molecular Pathology of Endometrial Cancer.

Surgical pathology clinics·2026

Same journal

Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Surgical pathology clinics·2026

Same journal

Oncogenicity and Therapeutic Implications of Molecular Biomarkers in Colorectal Carcinoma.

Surgical pathology clinics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 24, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Lymphoma Microenvironment and Immunotherapy.

Mina L Xu¹, Yuri Fedoriw²

¹Department of Pathology & Laboratory Medicine, Yale University School of Medicine, 310 Cedar Street, PO Box 208023, New Haven, CT 06520-8023, USA.

Surgical Pathology Clinics

|March 5, 2016

Summary

This summary is machine-generated.

Future lymphoma therapies require understanding the tumor microenvironment. This review explores its composition, role in immune evasion and drug resistance, and potential for targeted treatments.

Keywords:

Immune checkpoint Immune surveillance Immunomodulatory drugs Tumor microenvironment Tumor-associated macrophages

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Mar 24, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

Area of Science:

Oncology
Immunology
Genomics

Background:

Lymphoma tumor microenvironment (TME) research lags behind tumor cell characterization.
Next-generation sequencing advances TME understanding.
Interactions within the TME are crucial for effective lymphoma therapies.

Purpose of the Study:

To explore the composition of the lymphoma TME.
To elucidate the TME's role in immune surveillance, evasion, and drug resistance.
To discuss the TME's potential in developing targeted therapies.

Main Methods:

Literature review and synthesis of current research on lymphoma TME.
Analysis of studies focusing on cellular and molecular components of the TME.
Exploration of TME's influence on therapeutic response.

Main Results:

The TME comprises diverse cellular and non-cellular components influencing lymphoma progression.
TME plays a significant role in immune evasion and resistance to therapies.
Specific TME interactions present opportunities for novel therapeutic strategies.

Conclusions:

A deeper understanding of the lymphoma TME is essential for advancing treatment strategies.
Targeting TME interactions holds promise for overcoming drug resistance and improving patient outcomes.
Future research should focus on dissecting TME complexities for personalized lymphoma therapy.